Stock Track | CareDx Plunges as Slowing Growth Outlook Overshadows Strong Q3

Stock Track11-06

CareDx Inc (NASDAQ: CDNA) shares plummeted nearly 9% in pre-market trading on Monday, despite reporting strong third-quarter results that beat Wall Street expectations. The decline appears to be driven by concerns over the company's slowing growth outlook for 2025, overshadowing its impressive performance in the latest quarter.

For the third quarter of 2024, CareDx reported a 23% year-over-year increase in revenue to $82.9 million, surpassing analysts' estimates of $80.5 million. The company also achieved positive adjusted EBITDA of $6.9 million, marking a significant improvement from a loss of $10.9 million in the same period last year. Additionally, CareDx generated $12.5 million in cash from operations and ended the quarter with a robust cash balance of $241 million and no debt.

However, the company's guidance for 2025 revenue growth in the low-teens percentage range appears to have disappointed investors, sparking concerns about its ability to sustain the strong momentum witnessed in recent quarters. This guidance, coupled with ongoing legal challenges, pressure on product margins, and uncertainty around Medicare reimbursement, has weighed heavily on investor sentiment, leading to the sharp pre-market decline in CareDx's stock price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144878959?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-06 00:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144878959","market":"hk","top_or_hot":-1,"title":"Stock Track | CareDx Plunges as Slowing Growth Outlook Overshadows Strong Q3","media":"Stock Track","content":"<p>CareDx Inc (NASDAQ: CDNA) shares plummeted nearly 9% in pre-market trading on Monday, despite reporting strong third-quarter results that beat Wall Street expectations. The decline appears to be driven by concerns over the company's slowing growth outlook for 2025, overshadowing its impressive performance in the latest quarter.</p>\n\n<p>For the third quarter of 2024, CareDx reported a 23% year-over-year increase in revenue to $82.9 million, surpassing analysts' estimates of $80.5 million. The company also achieved positive adjusted EBITDA of $6.9 million, marking a significant improvement from a loss of $10.9 million in the same period last year. Additionally, CareDx generated $12.5 million in cash from operations and ended the quarter with a robust cash balance of $241 million and no debt.</p>\n\n<p>However, the company's guidance for 2025 revenue growth in the low-teens percentage range appears to have disappointed investors, sparking concerns about its ability to sustain the strong momentum witnessed in recent quarters. This guidance, coupled with ongoing legal challenges, pressure on product margins, and uncertainty around Medicare reimbursement, has weighed heavily on investor sentiment, leading to the sharp pre-market decline in CareDx's stock price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CareDx Plunges as Slowing Growth Outlook Overshadows Strong Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CareDx Plunges as Slowing Growth Outlook Overshadows Strong Q3\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-06 00:42 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CareDx Inc (NASDAQ: CDNA) shares plummeted nearly 9% in pre-market trading on Monday, despite reporting strong third-quarter results that beat Wall Street expectations. The decline appears to be ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"","article_id":"1144878959","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144878959","pubTimestamp":1730824951,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CareDx Inc  shares plummeted nearly 9% in pre-market trading on Monday, despite reporting strong third-quarter results that beat Wall Street expectations. The decline appears to be driven by concerns over the company's slowing growth outlook for 2025, overshadowing its impressive performance in the latest quarter.For the third quarter of 2024, CareDx reported a 23% year-over-year increase in revenue to $82.9 million, surpassing analysts' estimates of $80.5 million. The company also achieved posi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx"},"translate_title":"由于增长前景放缓盖过了强劲的第三季度，CareDx股价暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1},"content_text":"CareDx Inc (NASDAQ: CDNA) shares plummeted nearly 9% in pre-market trading on Monday, despite reporting strong third-quarter results that beat Wall Street expectations. The decline appears to be driven by concerns over the company's slowing growth outlook for 2025, overshadowing its impressive performance in the latest quarter.\nFor the third quarter of 2024, CareDx reported a 23% year-over-year increase in revenue to $82.9 million, surpassing analysts' estimates of $80.5 million. The company also achieved positive adjusted EBITDA of $6.9 million, marking a significant improvement from a loss of $10.9 million in the same period last year. Additionally, CareDx generated $12.5 million in cash from operations and ended the quarter with a robust cash balance of $241 million and no debt.\nHowever, the company's guidance for 2025 revenue growth in the low-teens percentage range appears to have disappointed investors, sparking concerns about its ability to sustain the strong momentum witnessed in recent quarters. This guidance, coupled with ongoing legal challenges, pressure on product margins, and uncertainty around Medicare reimbursement, has weighed heavily on investor sentiment, leading to the sharp pre-market decline in CareDx's stock price.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144878959"}